These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 32842055)

  • 21. Changes in Liver Stiffness and Noninvasive Fibrosis Scores in Egyptian Adolescents Successfully Treated with Ledipasvir-Sofosbuvir for Chronic Hepatitis C Virus Infection.
    Fahmy DM; Shokeir M; El Zeiny SM; Jonas MM; Abdallah A
    J Pediatr; 2021 Apr; 231():110-116. PubMed ID: 33347957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin resistance is associated with liver stiffness in HIV/HCV co-infected patients.
    Merchante N; Rivero A; de Los Santos-Gil I; Merino D; Márquez M; López-Ruz MA; Rodríguez-Baño J; Del Valle J; Camacho A; Sanz-Sanz J; Macías J; Pérez-Camacho I; Gómez-Mateos J; Moro A; Pineda JA
    Gut; 2009 Dec; 58(12):1654-60. PubMed ID: 19625279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The diagnostic accuracy of Fibroscan for cirrhosis is influenced by liver morphometry in HCV patients with a sustained virological response.
    D'Ambrosio R; Aghemo A; Fraquelli M; Rumi MG; Donato MF; Paradis V; Bedossa P; Colombo M
    J Hepatol; 2013 Aug; 59(2):251-6. PubMed ID: 23528378
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low risk of liver decompensation among human immunodeficiency virus/hepatitis C virus-coinfected patients with mild fibrosis in the short term.
    Macías J; Mancebo M; Márquez M; Merino D; Téllez F; Rivero A; von Wichmann MA; López-Cortés LF; Merchante N; Santos J; Raffo M; Pérez-Pérez M; Camacho Á; Iribarren JA; Pineda JA
    Hepatology; 2015 May; 61(5):1503-11. PubMed ID: 25545020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of transient elastography on clinical decision-making in patients with chronic viral hepatitis.
    Feuth T; Arends JE; Lieveld FI; Mundt MW; Hoepelman AI; Siersema PD; van Erpecum KJ
    Scand J Gastroenterol; 2013 Sep; 48(9):1074-81. PubMed ID: 23886398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of HIV infection, hepatitis C virus infection, and metabolic factors with liver stiffness measured by transient elastography.
    Bailony MR; Scherzer R; Huhn G; Plankey MW; Peters MG; Tien PC
    J Infect Dis; 2013 Dec; 208(11):1776-83. PubMed ID: 23901097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of liver fibrosis by transient elastography in persons with hepatitis C virus infection or HIV-hepatitis C virus coinfection.
    Kirk GD; Astemborski J; Mehta SH; Spoler C; Fisher C; Allen D; Higgins Y; Moore RD; Afdhal N; Torbenson M; Sulkowski M; Thomas DL
    Clin Infect Dis; 2009 Apr; 48(7):963-72. PubMed ID: 19236273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advanced liver fibrosis by transient elastography, fibrosis 4, and alanine aminotransferase/platelet ratio index among Asian hepatitis C with and without human immunodeficiency virus infection: role of vitamin D levels.
    Avihingsanon A; Jitmitraparp S; Tangkijvanich P; Ramautarsing RA; Apornpong T; Jirajariyavej S; Putcharoen O; Treeprasertsuk S; Akkarathamrongsin S; Poovorawan Y; Matthews GV; Lange JM; Ruxrungtham K;
    J Gastroenterol Hepatol; 2014 Sep; 29(9):1706-14. PubMed ID: 24730732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic performance of APRI and FIB-4 for confirming cirrhosis in Indonesian HIV/HCV co-infected patients.
    Yunihastuti E; Wicaksana B; Wiraguna A; Hidayah AJ; Amelia F; Natali V; Widhani A; Sulaiman AS; Kurniawan J
    BMC Infect Dis; 2020 May; 20(1):372. PubMed ID: 32450844
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liver stiffness measurements to assess progression of fibrosis in HCV-infected patients with inherited bleeding disorders.
    Fransen van de Putte DE; Fischer K; de Knegt RJ; Posthouwer D; van Erpecum KJ; Mauser-Bunschoten EP
    Haemophilia; 2011 Sep; 17(5):e975-80. PubMed ID: 21535322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-invasive assessment of liver steatosis and fibrosis in HIV/HCV- and HCV- infected patients.
    Li Vecchi V; Giannitrapani L; Di Carlo P; Mazzola G; Colletti P; La Spada E; Vizzini G; Montalto G; Soresi M
    Ann Hepatol; 2013; 12(5):740-8. PubMed ID: 24018492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in liver stiffness after ART initiation in HIV-infected Nigerian adults with and without chronic HBV.
    Grant JL; Agaba P; Ugoagwu P; Muazu A; Okpokwu J; Akpa S; Machenry S; Imade G; Agbaji O; Thio CL; Murphy R; Hawkins C
    J Antimicrob Chemother; 2019 Jul; 74(7):2003-2008. PubMed ID: 31225612
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modifications of liver stiffness and CXCL4, TGF-β1 and HGF are similar in HCV- and HIV/HCV-infected patients after DAAs.
    Márquez-Coello M; Arizcorreta A; Rodríguez-Pardo M; Illanes-Álvarez F; Márquez D; Cuesta-Sancho S; Girón-González JA
    Sci Rep; 2021 May; 11(1):9824. PubMed ID: 33972651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term evolution in liver fibrosis and immune profile after direct-acting antivirals therapy in hepatitis C virus-human immunodeficiency virus co-infected patients.
    Laguno M; Martínez-Rebollar M; Casanova M; de Lazzari E; González-Cordón A; Torres B; Inciarte A; Mora L; Ugarte A; Ambrosioni J; Blanco JL; Martínez E; Mallolas J
    Clin Microbiol Infect; 2022 Apr; 28(4):610.e1-610.e7. PubMed ID: 34464735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevated liver stiffness is linked to increased biomarkers of inflammation and immune activation in HIV/hepatitis C virus-coinfected patients.
    Medrano LM; Garcia-Broncano P; Berenguer J; González-García J; Jiménez-Sousa MÁ; Guardiola JM; Crespo M; Quereda C; Sanz J; Canorea I; Carrero A; Hontañón V; Muñoz-Fernández MÁ; Resino S;
    AIDS; 2018 Jun; 32(9):1095-1105. PubMed ID: 29438197
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Noninvasive assessment of liver fibrosis can predict clinical outcomes at late follow-up after a sustained virological response in HCV patients?
    Ragazzo TG; Zitelli PMY; Mazo DF; Oliveira CP; Carrilho FJ; Pessoa MG
    Clinics (Sao Paulo); 2024; 79():100381. PubMed ID: 38733689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Association of PNPLA3, COX-2 and DHCR7 Polymorphisms with Advanced Liver Fibrosis in Patients with HCV Mono- Infection and HCV/HIV Co-Infection.
    Kiatbumrung R; Chuaypen N; Payungporn S; Avihingsanon A; Tangkijvanich P
    Asian Pac J Cancer Prev; 2018 Aug; 19(8):2191-2197. PubMed ID: 30139224
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A matched cross-sectional study of the association between circulating tissue factor activity, immune activation and advanced liver fibrosis in hepatitis C infection.
    Hodowanec AC; Lee RD; Brady KE; Gao W; Kincaid S; Plants J; Bahk M; Mackman N; Landay AL; Huhn GD
    BMC Infect Dis; 2015 Apr; 15():190. PubMed ID: 25884329
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transient elastography: a non-invasive tool for assessing liver fibrosis in HIV/HCV patients.
    Li Vecchi V; Soresi M; Colomba C; Mazzola G; Colletti P; Mineo M; Di Carlo P; La Spada E; Vizzini G; Montalto G
    World J Gastroenterol; 2010 Nov; 16(41):5225-32. PubMed ID: 21049556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DAAs therapy associated with improved hepatic fibrosis in HCV-GT4 patients co-infected with HIV.
    El-Garem H; AbdAllah M; Omar H; Cordie A; Abdel Alem S; Mohey Eldin Elzahry MA; Ghaith D; Abou El-Soud NH; Kamal W; Elsharkawy A; Esmat G
    Expert Rev Gastroenterol Hepatol; 2019 Jul; 13(7):693-698. PubMed ID: 31043104
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.